2,326
Views
5
CrossRef citations to date
0
Altmetric
Short Communication

Lipid-lowering property of Clausena anisum-olens in hypercholesterolemic rats

, &
Pages 833-836 | Received 09 May 2016, Accepted 04 Nov 2016, Published online: 31 Jan 2017

References

  • Adebajo A, Iwalewa E, Obuotor E, Ibikunle G, Omisore N, Adewunmi C, Obaparusi O, Klaes M, Adetogun GE, Schmidt TJ, Verspohl EJ. 2009. Pharmacological properties of the extract and some isolated compounds of Clausena lansium stem bark: anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects. J Ethnopharmacol. 122:10–19.
  • Bruns C, Kemnitz J. 2004. Sex hormones, insulin sensitivity, and diabetes mellitus. ILAR J. 45:160–169.
  • Deepa P, Varalakshmi P. 2005. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats. Clin Chim Acta. 355:119–130.
  • De Guzman G, Ysrael M, Dacanay A, Dimaano J. 2013. Comparative hypolipidemic properties between the lyophilized fruit juice of Morinda citrifolia L. (Rubiaceae) and lyophilized commercial noni juice in triton and atherogenic diet-induced dyslipidemic rats. Intl J Pharm Teach Prac. 4:631–635.
  • De Zwart L, Meerman J, Commandeur J, Vermeulen N. 1999. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med. 26:202–226.
  • Golomb B, Evans M. 2008. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 8:373–418.
  • Gundaramanju R, Hwi K, Mulapalli S. 2014. Antihyperlipidemic potential of Albizia amara (Roxb) Boiv., bark against Triton X-100 induced hyperlipidemic condition in rats. Pharmacog Res. 6:267–273.
  • Khan N, Naqvi S. 1988. Constituents of the genus Clausena. J Sci Ind Res. 47:543–546.
  • Maneerat W, Prawat U, Saewan N, Laphookhieo S. 2010. New coumarins from Clausena lansium twigs. J Braz Chem Soc. 21:665–668.
  • Manosroi A, Saraphanchotiwitthaya A, Manosroi J. 2003. Immunomodulatory activities of Clausena excavata Burm. f. wood extracts. J Ethnopharmacol. 89:155–160.
  • Ojewole J. 2002. Hypoglycaemic effect of Clausena anisata (Willd) Hook methanolic root extract in rats. J Ethnopharmacol. 81:231–237.
  • Rachh P, Rachh M, Ghadiya N, Modi D, Modi K, Patel N, Rupareliya M. 2010. Antihyperlipidemia activity of Gymenma sylvestre R. Br. leaf extract on rats fed with high cholesterol diet. Int J Pharmacol. 6:138–141.
  • Wang Y, He H, Yang J, Di Y, Hao Z. 2008. New monoterpenoid coumarins from Clausena anisum-olens. Molecules. 13:931–937.
  • Wang Y, Xu H, Wang D, Yang J. 2009. A new O-terpenoidal coumarin from Clausena anisum-olens Merr. Molecules. 14:771–776.
  • WHO. 2015. World Health Organization, Obesity and Overweight, Fact sheet No. 311[Internet]. [cited 2015 Jan]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
  • Wu T, Huang S, Wu P, Teng C. 1996. Carbazole alkaloids from Clausena excavata and their biological activity. Phytochemistry. 43:133–140.
  • Yang M, Chen Y, Huang L. 1988. Three novel cyclic amides from Clausena lansium. Phytochemistry. 27:445–450.